AR042210A1 - PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX) - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX)Info
- Publication number
- AR042210A1 AR042210A1 ARP030104350A AR042210A1 AR 042210 A1 AR042210 A1 AR 042210A1 AR P030104350 A ARP030104350 A AR P030104350A AR 042210 A1 AR042210 A1 AR 042210A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- solvate
- acceptable salt
- functional derivative
- cyclloxygenase
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulación farmacéutica que comprende un agente antagonista de LTB, que tiene un grupo hidroxi y un grupo benzamidino, o un tautómero, una sal farmacéuticamente aceptable, un solvato, o un derivado fisiológicamente funcional del mismo, en particular un compuesto de fórmula (1), en el que R y A son como se han definido en las reivindicaciones, o un tautómero, una sal farmacéuticamente aceptable, un solvato o un derivado fisiológicamente funcional del mismo (1) y por lo menos un agente inhibidor de ciclooxigenasa-2, un agente inhibidor de cox1/2 combinado, o una sal farmacéuticamente aceptable, un solvato o un derivado fisiológicamente funcional del mismo (2), y un vehículo o excipiente farmacéuticamente aceptable, y opcionalmente uno o más de otros ingredientes terapéuticos. Método para la prevención o el tratamiento de artritis reumatoide, dermatitis atópica y enfermedad cardiaca coronaria entre otras.Pharmaceutical formulation comprising an LTB antagonist agent, which has a hydroxy group and a benzamidino group, or a tautomer, a pharmaceutically acceptable salt, a solvate, or a physiologically functional derivative thereof, in particular a compound of formula (1), wherein R and A are as defined in the claims, or a tautomer, a pharmaceutically acceptable salt, a solvate or a physiologically functional derivative thereof (1) and at least one cyclooxygenase-2 inhibiting agent, an agent combined cox1 / 2 inhibitor, or a pharmaceutically acceptable salt, a solvate or a physiologically functional derivative thereof (2), and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients. Method for the prevention or treatment of rheumatoid arthritis, atopic dermatitis and coronary heart disease among others.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP030104350 AR042210A1 (en) | 2003-11-26 | 2003-11-26 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP030104350 AR042210A1 (en) | 2003-11-26 | 2003-11-26 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042210A1 true AR042210A1 (en) | 2005-06-15 |
Family
ID=42777791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030104350 AR042210A1 (en) | 2003-11-26 | 2003-11-26 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX) |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR042210A1 (en) |
-
2003
- 2003-11-26 AR ARP030104350 patent/AR042210A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28510A1 (en) | CHEMICAL COMPOUNDS | |
| PE20070541A1 (en) | COMPOUNDS AND COMPOSITIONS INCLUDING ISOINDOL-IMIDES | |
| AR050838A1 (en) | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OPTICAL INFECTION | |
| PA8587101A1 (en) | NEW DERIVATIVES OF DIHYDROPIRIMIDO [4,5-D] PIRIMIDINONE REPLACED BY AMIINO, MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS | |
| BRPI0509172A (en) | at least one chemical entity, pharmaceutical composition, methods for treating a patient, inhibiting at least one enzyme using atp, and treating at least one disease, use of at least one chemical entity, and method for the manufacture of a medicament | |
| CR8411A (en) | METHOD FOR TREATMENT OF THE DISEASE ASSOCIATED WITH ADAMTS-5 | |
| ECSP055595A (en) | DERIVATIVES OF HETEROBIARILO AS METALOPROTEINASE IN MATRIX INHIBITORS | |
| UY26635A1 (en) | SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| AR058780A1 (en) | IMIDAZOPIRAZINAS AS INHIBITORS OF CYCLINE-DEPENDENT KINASES | |
| AR063096A1 (en) | PIRAZOLOPIRIMIDINAS AS INHIBITORS OF CYCLINE-DEPENDENT KINASE | |
| AR051405A1 (en) | 2-CARBOXAMIDE (3-AMINO) THIOPHENE COMPOUNDS | |
| BRPI0509074A (en) | pharmaceutical compositions comprising thyroid receptor agonists | |
| PA8603201A1 (en) | PROCEDURE AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTEROSCLEROSIS, DISLIPIDEMIAS AND RELATED AFFECTIONS | |
| PE20060594A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A PPAR AGONIST | |
| BRPI0416752A (en) | pharmaceutical composition, use of one or more compounds, method for the prevention or treatment of disorders, compounds, and process for the preparation of a pharmaceutical composition | |
| ES2340502T3 (en) | COMPOUNDS OF 1,4,8-TRIAZAESPIRO (4,5) DECAN-2-ONA SUBSTITUTED FOR THE TREATMENT OF OBESITY. | |
| GT200600160A (en) | PAIN TREATMENT | |
| NO20050096L (en) | Combinations that include epothilones and their pharmaceutical applications | |
| UY26564A1 (en) | FACTOR XA INHIBITORS WITH ARYL - AMIDINES AND THEIR DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ECSP077262A (en) | ANTIHISTAMINAL COMPOSITION | |
| CO2019004004A2 (en) | Pharmaceutical composition and method for the treatment of non-alcoholic fatty liver disease | |
| ES2129448T3 (en) | USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS. | |
| AR042210A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ANTIGONISTS OF LEUCOTRIENS B4 (LTB4) AND INHIBITORS OF CYCLLOXYGENASE (COX) | |
| AR057403A1 (en) | 4- ANILINO-3-QUINOLINCARBONITRILOS FOR THE TREATMENT OF CANCER | |
| PA8579701A1 (en) | BETA-LACTAMASA INHIBITOR PROFARMACO |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |